Methyl dec-9-enoate

CAS No. 25601-41-6

Methyl dec-9-enoate( —— )

Catalog No. M37418 CAS No. 25601-41-6

Methyl dec-9-enoate (9-Decenoic acid methyl ester) is an olefin ester oil displacing agent, and is a raw material for coatings, inks and plastic additives.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 30 In Stock
25MG 44 In Stock
50MG 62 In Stock
100MG 86 In Stock
200MG 124 In Stock
500MG 206 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl dec-9-enoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl dec-9-enoate (9-Decenoic acid methyl ester) is an olefin ester oil displacing agent, and is a raw material for coatings, inks and plastic additives.
  • Description
    Methyl dec-9-enoate (9-Decenoic acid methyl ester) is an olefin ester oil displacing agent, and is a raw material for coatings, inks and plastic additives.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    25601-41-6
  • Formula Weight
    184.28
  • Molecular Formula
    C11H20O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)CCCCCCCC=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Donanemab

    Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a pyroglutamate amyloid beta (Aβ) epitope at the N-terminus, showing potential for early Alzheimer's disease research .

  • Mepacrine

    Mepacrine (Erion) is an acridine derivative formerly widely used as an antimalarial. It is used in cell biological experiments as an inhibitor of phospholipase A2.

  • 1-Phenylbiguanide HC...

    Compound PDK0269, as 5-HT3 receptor agonists(3–100 μM, pEC50 5.05±0.06), acutely increased XII (hypoglossal) burst frequency and regularity, and decreased bursts/episode .